U.S. Endoscope Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)

U.S. Endoscope Market Size

U.S. Endoscope Market Trends & Growth Drivers

Increasing Number of Product Launches Is Key Trend

• The U.S. endoscopes market has seen a significant rise in the number of new product launches in recent years.
• Leading market players are continuously developing and introducing advanced endoscopic devices to fulfill the increasing need for minimally invasive diagnostic and treatment procedures.
• For instance, in 2024, Olympus Corporation announced the launch of two new bronchoscopes as part of its EVIS X1 Endoscopy System for diagnostic and therapeutic bronchoscopy.
• Similarly, FUJIFILM Healthcare Americas Corporation has introduced the FDA-approved EI-740D/S dual-channel endoscope for both upper and lower GI procedures.
• As EI-740D/S provides a high imaging quality and features dual channels with diameters of 3.7 mm and 3.2 mm, allowing for the use of various endotherapy devices. This innovation enhances the versatility and efficiency of gastrointestinal endoscopic procedures.

Increasing Incidence of Gastrointestinal Disorders Is Major Growth Driver

• The increasing prevalence of gastrointestinal disorders, such as irritable bowel syndrome, colorectal cancer, and Crohn's disease, is raising the demand for endoscopic procedures.
• As per the GI Alliance, 20 million Americans are affected by chronic digestive diseases, which account for 25% of all surgical procedures. Further, these conditions are a major cause of disability in offices and result in more hospitalizations than any other condition.
• Economically, digestive diseases rank third among all illnesses in the U.S., contributing to significant healthcare costs. Annually, 14 million acute digestive disease cases are treated in the country, including around 75% of all metastases and some common acute infections.
• These diseases have a significant impact, resulting in considerable discomfort, pain, financial burden, lost productivity, and loss of life. Specifically, colorectal cancer, which is the second-most-common cause of cancer-related deaths in both American men and women, leads to more than 51,000 fatalities annually.
• All these diseases necessitate regular endoscopic screenings and interventions, thus contributing to market growth.

High Cost Is Challenging Factor

• The high costs linked with endoscopic devices pose a significantly constraint on the U.S. endoscopes market.
• Endoscopes, especially those equipped with advanced features, such as HD imaging and AI, can be prohibitively expensive.
• Sophisticated and advanced endoscopic instruments can cost USD 50,000 to USD 60,000 or even more, making them a substantial item in a hospital's budget.
• The cost of training healthcare professionals to effectively use these advanced instruments is another financial consideration, as comprehensive training programs are necessary to ensure that healthcare practitioners can operate the latest endoscopic technologies safely and efficiently.
• These training programs, while essential, add to the overall expenditure, making it challenging for some institutions to adopt new technologies

U.S. Endoscope Market Analysis

Type Insights

• Flexible endoscopes hold the larger share in 2024 in the U.S. endoscopes market, and they are also expected to witness the higher CAGR.
• This is mainly due to their versatility, patient comfort, as well as the broad range of procedures they support.
• Because flexible endoscopes are designed to navigate complex and curved internal structures in the body, they are suitable for a wide range of diagnostic and therapeutic procedures, most prominently GI endoscopy, bronchoscopy and ureteroscopy.
• Moreover, the demand for them is propelled by their application in minimally invasive procedures, such as colonoscopies, upper GI endoscopies, and bronchoscopies.
• Flexible endoscopes also provide greater patient comfort compared to rigid endoscopes. This is due to their flexibility, which allows them to maneuver through the body's natural curves without causing any discomfort.
• This is particularly important for procedures such as colonoscopies and gastroscopies, where the endoscope must travel long and winding pathways inside the body.
• The minimally invasive nature of flexible endoscopes significantly leads to shorter recovery times and fewer complications and often allows procedures to be performed on an outpatient basis, which is a significant benefit to both patients and healthcare providers.

This segment is divided into the following categories:

• Flexible (Larger and Faster-Growing Type)
• Rigid

End User insights

• The hospitals category holds the largest market share in 2024. This is mainly due to the high patient volumes, modern infrastructure, and significant investment in medical technology.
• Moreover, hospitals perform a wide range of endoscopic procedures, ranging from diagnostic to therapeutic interventions.
• These include colonoscopies, bronchoscopies, gastroscopies, and more-complex surgeries, such as laparoscopies and endoscopic retrograde cholangiopancreatography (ERCP). The ability to offer such a wide variety of procedures makes hospitals the major consumers of endoscopic devices.

During the study, three categories were analyzed:

• Hospitals (Largest Category)
• Ambulatory Surgery Centers/Clinics (Fastest-Growing Category)
• Others

Geographical Analysis

California is the largest market in the country, with a share of 13% in 2024. It is also expected to witness the fastest growth during the forecast period. This is mainly due to the advanced healthcare infrastructure, increasing prevalence of chronic diseases, and ethnically diverse population in this state.

According to the Public Policy Institute of California (PPIC), as of July 2023, California's population stands at over 39 million, which is significantly larger than that of Texas, which holds the second place with 31 million residents; and Florida in the third place with 23 million residents. In addition, the California Department of Finance estimates that the state's population will grow to 40.2 million by 2044.

These states were analyzed for this report:

• California (Largest and Fastest-Growing State)
• Texas
• Florida
• Pennsylvania
• New Jersey
• Maryland
• North Carolina
• Georgia
• Ohio
• Illinois
• Washington
• Arizona
• Colorado
• New York
• Missouri
• Others

U.S. Endoscope Market Share

The U.S. endoscope market is fragmented in nature with the presence of several key players and new entrants. Key companies, such as Olympus Corporation of the Americas, Boston Scientific Corporation, and Medtronic plc, dominate the market. In recent years, the market players in the U.S. endoscope industry have been involved in product launches in order to gain a prominent position.

U.S. Endoscope Market News

In June 2024, KARL STORZ SE & Co. KG gained approval for the Solo+ ear tube placement device, which enables patients and physicians to efficiently perform pediatric ENT surgeries in a simple and quick manner.

In May 2024, Cook Medical LLC launched the next generation of EchoTip AcuCore EUS biopsy needle in the U.S. The 22-gauge AcuCore needle is designed for use in endoscopic ultrasound for the fine-needle biopsy of extramural and submucosal lesions, lymph nodes, mediastinal masses, and intraperitoneal masses adjacent to or within the GI tract. The AcuCore needle has a Franseen tip made from an alloy of cobalt and chromium, which lets doctors puncture tissue with minimum force, flexibility, and controlled precision. To offer high flexibility, the cobalt–chromium alloy has been combined with a spring-coiled sheath, coated on the inside and outside, thereby offering simpler access to difficult anatomy.

In January 2024, Arthrex Inc. introduced a new patient-focused resource, TheNanoExperience.com, which showcases nano arthroscopy. This minimally invasive orthopedic procedure is designed to promote a rapid return to activity and reduce discomfort.

In November 2023, Ethicon Endo-Surgery Inc. unveiled an AI-powered surgical simulation platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This technology marks a significant advancement in surgical training, integrating AI, AR, real-time data, and tactical feedback.

In October 2023, PENTAX Medical launched two of its PENTAX Medical INSPIRA (EPK-i8020c) and ergonomic i20c endoscopes in the U.S.